Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : TAVA Technologies (TAVA-NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: TH who wrote (27686)	2/10/1999 10:00:00 AM
From: JDN	Read Replies (1) \| Respond to of 31646

Dear Mathew: As a matter of Policy, TAVA NEVER gives projections of any kind to anyone--not even the analyst. I dont have enough info yet to make an accurate projection for the 3/31 qtr. (have requested some items). However, I think that it is a safe bet to assume that the Labor Revenue will grow (ie higher average number of employees and subcontractors and I presume they are all working hard based upon some comments I heard the COO make) the 500M license fee from the medical group will not be there and no royalties either from them until next qtr. But I seem to recall there would be some offsetting expense reductions like those associated with Mangan and Mangan should kick in one month of activity (March). So as a minimum I am going to, for now, presume no worse than this qtr. Then from there subtract something for taxes. I have a feeling even this qtr wont get a full tax hit. I will probably assume half. JDN